Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has informed the BSE that its trading window for dealing in company securities will be closed starting Wednesday, 1st October 2025, until 48 hours after the declaration of unaudited financial results for the quarter ended 30th September 2025. This closure is in compliance with SEBI's Insider Trading Regulations, 2015 and the company's internal code of conduct. The date of the upcoming board meeting to consider and approve the Q2 FY26 results has not yet been announced and will be communicated later.
This is a routine compliance announcement ahead of quarterly results. Insiders, directors, and certain employees cannot trade in the stock during the closed window. No direct material impact on shareholders is expected, but the upcoming results declaration could be a catalyst for price movement once the window reopens.